A personalized approach to lowering cholesterol is crucial in preventing heart attacks, as the optimal level, speed, and duration of low-density lipoprotein (LDL) reduction can vary from person to ...

Evaluation for pulmonary hypertension (PH) in patients with cancer must include either lung ventilation/perfusion scan or dual-energy computed tomography of the chest to evaluate for acute and/or ...

JACC: CardioOncology recognizes the importance of education, research and advocacy in advancing the understanding and management of amyloidosis. Check out the journal's Amyloidosis Hub, highlighting ...

This series of podcasts sponsored by the ACC’s Women in Cardiology (WIC) Section and led by Dr. Angela Koh. In this episode, Dr. Koh hosts Drs. Sharmila Dorbala and Victoria Delgado who share their ...

The U.S. Food and Drug Administration (FDA) announced on March 3 that Philips is removing and discontinuing distribution of the Tack Endovascular System due to challenges necessitating additional ...

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...

Join cardiovascular interventionists from ACC's Women in Cardiology Member Section International Work Group on Tuesday, April 22 at 6 p.m. ET as they share insights on how to balance a thriving career ...

JACC: Case Reports is calling for submissions for a special issue on Multi-Valve Disease. In partnership with the Heart Valve Collaboratory, the issue will feature work alongside expert editorials ...

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major ...

Notifying patients and their clinicians about incidental coronary calcium findings can encourage shared decision-making on preventive therapies and significantly boost statin use among high-risk ...